Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence

1 Aug 2021

Abstract excerpt

Purpose: Accurate molecular diagnostic assays for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, are needed for epidemiology studies and to support infection-control measures. We evaluated the analytical sensitivity and clinical performance of three sample-to-answer molecular-diagnostics systems for detecting SARS-CoV-2 using 325 nasopharyngeal swab...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biosensors and Analytical Detection
Share to Respiratory viral infections research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34429623
DOI: 10.2147/idr.s328327

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage EmergencePMID 34429623Read ↗

SARS-CoV-2 variant of concern B.1.1.7: diagnostic accuracy of three antigen-detecting rapid testsSemantic proximity Read ↗

Comparison of three molecular diagnostic assays for SARS‐CoV‐2 detection: Evaluation of analytical sensitivity and clinical performanceSemantic proximity Read ↗

Analytical Performance of the Point-of-care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceSemantic proximity Read ↗

Analytical Performances of the Point-of-Care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceSemantic proximity Read ↗

Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.Semantic proximity Read ↗

Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNASemantic proximity Read ↗

Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variantsSemantic proximity Read ↗

Validation of Reduced S-gene Target Performance and Failure for Rapid Surveillance of SARS-CoV-2 VariantsSemantic proximity Read ↗

Molecular Diagnosis of SARS-CoV-2: Assessing and Interpreting Nucleic Acid and Antigen TestsSemantic proximity Read ↗

Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike VariantSemantic proximity Read ↗

Sequencing SARS-CoV-2 from Antigen TestsSemantic proximity Read ↗

Sequencing SARS-CoV-2 from antigen testsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.